Professional Documents
Culture Documents
FORM 3
REPORTING OWNER
KEYSTONE CAPITAL PARTNERS, LLC Mailing Address Business Address
139 FULTON STREET 139 FULTON STREET
CIK:1865973| State of Incorp.:DE | Fiscal Year End: 1231 SUITE 412 SUITE 412
Type: 3 | Act: 34 | File No.: 000-51012 | Film No.: 211006033 NEW YORK NY 10038 NEW YORK NY 10038
(646) 349-0916
ISSUER
Healthtech Solutions, Inc./UT Mailing Address Business Address
181 DANTE AVENUE 181 DANTE AVENUE
CIK:1307624| IRS No.: 842528660 | State of Incorp.:UT | Fiscal Year End: 1231 TUCKAHOE NY 10707 TUCKAHOE NY 10707
SIC: 3841 Surgical & medical instruments & apparatus 844-926-3399
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section
17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the
Investment Company Act of 1940
1. Name and Address of Reporting Person * 2. Date of Event Requiring 3. Issuer Name and Ticker or Trading Symbol
Statement (Month/Day/
KEYSTONE CAPITAL Year) Healthtech Solutions, Inc./UT [HLTT]
PARTNERS, LLC 05/12/2021
4. Relationship of Reporting Person(s) to Issuer 5. If Amendment, Date Original Filed
(Last) (First) (Middle) (Check all applicable) (Month/Day/Year)
_____ Director __X__ 10% Owner
139 FULTON STREET, SUITE 412 _____ Officer (give title _____ Other (specify
below) below)
6. Individual or Joint/Group Filing
(Street) (Check applicable line)
__X__ Form Filed by One Reporting
Person
NEW YORK, NY 10038 _____ Form Filed by More than One
Reporting Person
(City) (State) (Zip)
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and 3. Title and Amount of Securities 4. 5. 6. Nature of Indirect
Expiration Date (Month/ Underlying Derivative Security (Instr. 4) Conversion Ownership Beneficial Ownership
Day/Year) or Exercise Form of (Instr. 5)
Price of Derivative
Date Expiration Derivative Security:
Exercisable Date Amount or
Number of Security Direct (D) or
Title
Shares Indirect (I)
(Instr. 5)
Explanation of Responses:
1. Each share of Series A Preferred Stock is convertible into 2,000 shares of common stock of the Issuer pursuant to the Articles of Amendment to
the Articles of Incorporation effective as of March 31, 2021 and filed with the Securities and Exchange Administration as Exhibit 3.1 to the
Issuer's 8-K filed May 12, 2021.
Signatures
/s/ Fredric G. Zaino 06/09/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.